Psychosocial intervention development for the prevention and treatment of depression: Promoting innovation and increasing access

Steven D. Hollon, Ricardo F. Muñoz, David H. Barlow, William R. Beardslee, Carl C. Bell, Guillermo Bernal, Gregory N. Clarke, L. Patt Franciosi, Alan E. Kazdin, Laura Kohn-Wood, Marsha M. Linehan, John C. Markowitz, David J. Miklowitz, Jacqueline B. Persons, George Niederehe, David Sommers

Research output: Contribution to journalArticle

185 Citations (Scopus)

Abstract

Great strides have been made in developing psychosocial interventions for the treatment of depression and bipolar disorder over the last three decades, but more remains to be done. The National Institute of Mental Health Psychosocial Intervention Development Workgroup recommends three priorities for future innovation: 1) development of new and more effective interventions that address both symptom change and functional capacity, 2) development of interventions that prevent onset and recurrence of clinical episodes in at-risk populations, and 3) development of user-friendly interventions and nontraditional delivery methods to increase access to evidence-based interventions. In each of these areas, the Workgroup recommends systematic study of the mediating mechanisms that drive the process of change and the moderators that influence their effects. This information will highlight the elements of psychosocial interventions that most contribute to the prevention and treatment of mood disorders across diagnostic groups, populations served, and community settings. The process of developing innovative interventions should have as its goal a mental health service delivery system that prevents the onset and recurrence of the mood disorders, furnishes increasingly effective treatment for those who seek it, and provides access to evidence-based psychosocial interventions via all feasible means.

Original languageEnglish
Pages (from-to)610-630
Number of pages21
JournalBiological Psychiatry
Volume52
Issue number6
DOIs
StatePublished - Sep 15 2002
Externally publishedYes

Fingerprint

Depression
Mood Disorders
National Institute of Mental Health (U.S.)
Recurrence
Mental Health Services
Bipolar Disorder
Population Groups
Therapeutics
Drive

Keywords

  • Depression
  • Prevention
  • Suicide
  • Translational
  • Transportability
  • Treatment

ASJC Scopus subject areas

  • Biological Psychiatry

Cite this

Hollon, S. D., Muñoz, R. F., Barlow, D. H., Beardslee, W. R., Bell, C. C., Bernal, G., ... Sommers, D. (2002). Psychosocial intervention development for the prevention and treatment of depression: Promoting innovation and increasing access. Biological Psychiatry, 52(6), 610-630. https://doi.org/10.1016/S0006-3223(02)01384-7

Psychosocial intervention development for the prevention and treatment of depression : Promoting innovation and increasing access. / Hollon, Steven D.; Muñoz, Ricardo F.; Barlow, David H.; Beardslee, William R.; Bell, Carl C.; Bernal, Guillermo; Clarke, Gregory N.; Franciosi, L. Patt; Kazdin, Alan E.; Kohn-Wood, Laura; Linehan, Marsha M.; Markowitz, John C.; Miklowitz, David J.; Persons, Jacqueline B.; Niederehe, George; Sommers, David.

In: Biological Psychiatry, Vol. 52, No. 6, 15.09.2002, p. 610-630.

Research output: Contribution to journalArticle

Hollon, SD, Muñoz, RF, Barlow, DH, Beardslee, WR, Bell, CC, Bernal, G, Clarke, GN, Franciosi, LP, Kazdin, AE, Kohn-Wood, L, Linehan, MM, Markowitz, JC, Miklowitz, DJ, Persons, JB, Niederehe, G & Sommers, D 2002, 'Psychosocial intervention development for the prevention and treatment of depression: Promoting innovation and increasing access', Biological Psychiatry, vol. 52, no. 6, pp. 610-630. https://doi.org/10.1016/S0006-3223(02)01384-7
Hollon, Steven D. ; Muñoz, Ricardo F. ; Barlow, David H. ; Beardslee, William R. ; Bell, Carl C. ; Bernal, Guillermo ; Clarke, Gregory N. ; Franciosi, L. Patt ; Kazdin, Alan E. ; Kohn-Wood, Laura ; Linehan, Marsha M. ; Markowitz, John C. ; Miklowitz, David J. ; Persons, Jacqueline B. ; Niederehe, George ; Sommers, David. / Psychosocial intervention development for the prevention and treatment of depression : Promoting innovation and increasing access. In: Biological Psychiatry. 2002 ; Vol. 52, No. 6. pp. 610-630.
@article{a1eb859c4750483c9094029bf9b71de9,
title = "Psychosocial intervention development for the prevention and treatment of depression: Promoting innovation and increasing access",
abstract = "Great strides have been made in developing psychosocial interventions for the treatment of depression and bipolar disorder over the last three decades, but more remains to be done. The National Institute of Mental Health Psychosocial Intervention Development Workgroup recommends three priorities for future innovation: 1) development of new and more effective interventions that address both symptom change and functional capacity, 2) development of interventions that prevent onset and recurrence of clinical episodes in at-risk populations, and 3) development of user-friendly interventions and nontraditional delivery methods to increase access to evidence-based interventions. In each of these areas, the Workgroup recommends systematic study of the mediating mechanisms that drive the process of change and the moderators that influence their effects. This information will highlight the elements of psychosocial interventions that most contribute to the prevention and treatment of mood disorders across diagnostic groups, populations served, and community settings. The process of developing innovative interventions should have as its goal a mental health service delivery system that prevents the onset and recurrence of the mood disorders, furnishes increasingly effective treatment for those who seek it, and provides access to evidence-based psychosocial interventions via all feasible means.",
keywords = "Depression, Prevention, Suicide, Translational, Transportability, Treatment",
author = "Hollon, {Steven D.} and Mu{\~n}oz, {Ricardo F.} and Barlow, {David H.} and Beardslee, {William R.} and Bell, {Carl C.} and Guillermo Bernal and Clarke, {Gregory N.} and Franciosi, {L. Patt} and Kazdin, {Alan E.} and Laura Kohn-Wood and Linehan, {Marsha M.} and Markowitz, {John C.} and Miklowitz, {David J.} and Persons, {Jacqueline B.} and George Niederehe and David Sommers",
year = "2002",
month = "9",
day = "15",
doi = "10.1016/S0006-3223(02)01384-7",
language = "English",
volume = "52",
pages = "610--630",
journal = "Biological Psychiatry",
issn = "0006-3223",
publisher = "Elsevier USA",
number = "6",

}

TY - JOUR

T1 - Psychosocial intervention development for the prevention and treatment of depression

T2 - Promoting innovation and increasing access

AU - Hollon, Steven D.

AU - Muñoz, Ricardo F.

AU - Barlow, David H.

AU - Beardslee, William R.

AU - Bell, Carl C.

AU - Bernal, Guillermo

AU - Clarke, Gregory N.

AU - Franciosi, L. Patt

AU - Kazdin, Alan E.

AU - Kohn-Wood, Laura

AU - Linehan, Marsha M.

AU - Markowitz, John C.

AU - Miklowitz, David J.

AU - Persons, Jacqueline B.

AU - Niederehe, George

AU - Sommers, David

PY - 2002/9/15

Y1 - 2002/9/15

N2 - Great strides have been made in developing psychosocial interventions for the treatment of depression and bipolar disorder over the last three decades, but more remains to be done. The National Institute of Mental Health Psychosocial Intervention Development Workgroup recommends three priorities for future innovation: 1) development of new and more effective interventions that address both symptom change and functional capacity, 2) development of interventions that prevent onset and recurrence of clinical episodes in at-risk populations, and 3) development of user-friendly interventions and nontraditional delivery methods to increase access to evidence-based interventions. In each of these areas, the Workgroup recommends systematic study of the mediating mechanisms that drive the process of change and the moderators that influence their effects. This information will highlight the elements of psychosocial interventions that most contribute to the prevention and treatment of mood disorders across diagnostic groups, populations served, and community settings. The process of developing innovative interventions should have as its goal a mental health service delivery system that prevents the onset and recurrence of the mood disorders, furnishes increasingly effective treatment for those who seek it, and provides access to evidence-based psychosocial interventions via all feasible means.

AB - Great strides have been made in developing psychosocial interventions for the treatment of depression and bipolar disorder over the last three decades, but more remains to be done. The National Institute of Mental Health Psychosocial Intervention Development Workgroup recommends three priorities for future innovation: 1) development of new and more effective interventions that address both symptom change and functional capacity, 2) development of interventions that prevent onset and recurrence of clinical episodes in at-risk populations, and 3) development of user-friendly interventions and nontraditional delivery methods to increase access to evidence-based interventions. In each of these areas, the Workgroup recommends systematic study of the mediating mechanisms that drive the process of change and the moderators that influence their effects. This information will highlight the elements of psychosocial interventions that most contribute to the prevention and treatment of mood disorders across diagnostic groups, populations served, and community settings. The process of developing innovative interventions should have as its goal a mental health service delivery system that prevents the onset and recurrence of the mood disorders, furnishes increasingly effective treatment for those who seek it, and provides access to evidence-based psychosocial interventions via all feasible means.

KW - Depression

KW - Prevention

KW - Suicide

KW - Translational

KW - Transportability

KW - Treatment

UR - http://www.scopus.com/inward/record.url?scp=0037106957&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0037106957&partnerID=8YFLogxK

U2 - 10.1016/S0006-3223(02)01384-7

DO - 10.1016/S0006-3223(02)01384-7

M3 - Article

C2 - 12361671

AN - SCOPUS:0037106957

VL - 52

SP - 610

EP - 630

JO - Biological Psychiatry

JF - Biological Psychiatry

SN - 0006-3223

IS - 6

ER -